QUANTITATIVE SCIENCES AND POPULATION RESEARCH GROUP CORE 013 ? RESEARCH INFORMATICS SHARED RESOURCE PROJECT SUMMARY / ABSTRACT The mission of the Vanderbilt-Ingram Cancer Center (VICC) Research Informatics Shared Resource (RISR) is to catalyze the research productivity of VICC investigators by providing common informatics services in a standardized fashion. These services include software development, shared research applications and shared data storage. The services currently provided by the RISR include technology support, application support, FISMA hosting, database support and clinical informatics support to enable clinical decision-making using genetic information (e.g., mycancergenome.org and other VICC applications). Additionally, the RISR supports clinical trials management via services for protocol, calendar and eCRF setup. Finally, custom development, data management and reporting services are available and managed through a project management lifecycle. A major focus of the RISR is secondary use of data sources such as NCI PDQ, tumor registry and industry- specific repositories, leveraging institutional resources and selection of tools based on vendor capabilities and reuse of technology solutions. Several of the significant activities within the RISR support the clinical trials management system along with data integration for use within reporting tools and dashboards. Additionally, the custom developed My Cancer Genome and VICC.org systems have been designed by the RISR to complement and integrate with CTSA and enterprise tools such as REDCap and Microsoft SharePoint.
The specific aims for the upcoming project period include:
Aim 1) Enhance RISR?s cancer-centric research data mart;
Aim 2) Improve investigator outreach;
Aim 3) Standardize a portfolio of tools to enhance clinical trials and cancer discovery.

Public Health Relevance

QUANTITATIVE SCIENCES AND POPULATION RESEARCH GROUP CORE 013 ? RESEARCH INFORMATICS SHARED RESOURCE PROJECT NARRATIVE Per the PAR-13-386 FOA, the project narrative is not applicable for the Research Informatics Shared Resource.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
6P30CA068485-20
Application #
9248557
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2016-04-30
Budget End
2016-08-31
Support Year
20
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Covington, Brett C; Spraggins, Jeffrey M; Ynigez-Gutierrez, Audrey E et al. (2018) Response of Hypogean Actinobacterial Genera Secondary Metabolism to Chemical and Biological Stimuli. Appl Environ Microbiol :
Hong, Jun; Maacha, Selma; Belkhiri, Abbes (2018) Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma. Mol Oncol 12:2191-2208
Dahlman, Kimberly Brown; Weinger, Matthew B; Lomis, Kimberly D et al. (2018) Integrating Foundational Sciences in a Clinical Context in the Post-Clerkship Curriculum. Med Sci Educ 28:145-154
Wu, Jie; Cai, Hui; Xiang, Yong-Bing et al. (2018) Intra-individual variation of miRNA expression levels in human plasma samples. Biomarkers 23:339-346
Bolus, W Reid; Peterson, Kristin R; Hubler, Merla J et al. (2018) Elevating adipose eosinophils in obese mice to physiologically normal levels does not rescue metabolic impairments. Mol Metab 8:86-95
Ramsey, Haley E; Fischer, Melissa A; Lee, Taekyu et al. (2018) A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia. Cancer Discov 8:1566-1581
Alvarado, Gabriela; Ettayebi, Khalil; Atmar, Robert L et al. (2018) Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses. Gastroenterology 155:1898-1907
Cardin, Dana B; Goff, Laura W; Chan, Emily et al. (2018) Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trial. Invest New Drugs 36:442-450
Yang, Jinming; Kumar, Amrendra; Vilgelm, Anna E et al. (2018) Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms. Cancer Immunol Res 6:1186-1198
Garcia, A Denise R; Han, Young-Goo; Triplett, Jason W et al. (2018) The Elegance of Sonic Hedgehog: Emerging Novel Functions for a Classic Morphogen. J Neurosci 38:9338-9345

Showing the most recent 10 out of 2462 publications